Percheron Therapeutics Ltd (PER) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.716x

Based on the latest financial reports, Percheron Therapeutics Ltd (PER) has a cash flow conversion efficiency ratio of -0.716x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-7.16 Million ≈ $-5.07 Million USD) by net assets (AU$10.00 Million ≈ $7.08 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Percheron Therapeutics Ltd - Cash Flow Conversion Efficiency Trend (2002–2025)

This chart illustrates how Percheron Therapeutics Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Percheron Therapeutics Ltd for a breakdown of total debt and financial obligations.

Percheron Therapeutics Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Percheron Therapeutics Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Minaean SP Construction Corp V:MSP	-1.154x
Teuza A Fairchild Technology Venture Ltd TA:TUZA	-0.017x
Wa Kaolin Ltd AU:WAK	-0.393x
Viji Finance Limited NSE:VIJIFIN	0.017x
Djasa Ubersakti Tbk JK:PTDU	-5.449x
Zonte Metals Inc V:ZON	0.000x
Urban One NASDAQ:UONE	-0.002x
Vinny Overseas Limited NSE:VINNY	0.031x

Annual Cash Flow Conversion Efficiency for Percheron Therapeutics Ltd (2002–2025)

The table below shows the annual cash flow conversion efficiency of Percheron Therapeutics Ltd from 2002 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Percheron Therapeutics Ltd worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$10.00 Million ≈ $7.08 Million	AU$-15.64 Million ≈ $-11.07 Million	-1.564x	-44.74%
2024-06-30	AU$9.36 Million ≈ $6.62 Million	AU$-10.12 Million ≈ $-7.16 Million	-1.080x	-32.22%
2023-06-30	AU$9.98 Million ≈ $7.06 Million	AU$-8.15 Million ≈ $-5.77 Million	-0.817x	-121.33%
2022-06-30	AU$21.14 Million ≈ $14.96 Million	AU$-7.81 Million ≈ $-5.52 Million	-0.369x	+63.76%
2021-06-30	AU$5.73 Million ≈ $4.05 Million	AU$-5.83 Million ≈ $-4.13 Million	-1.019x	-16.98%
2020-06-30	AU$4.53 Million ≈ $3.21 Million	AU$-3.95 Million ≈ $-2.79 Million	-0.871x	+16.46%
2019-06-30	AU$2.81 Million ≈ $1.99 Million	AU$-2.93 Million ≈ $-2.07 Million	-1.042x	-91.14%
2018-06-30	AU$4.22 Million ≈ $2.99 Million	AU$-2.30 Million ≈ $-1.63 Million	-0.545x	+65.32%
2017-06-30	AU$1.85 Million ≈ $1.31 Million	AU$-2.91 Million ≈ $-2.06 Million	-1.572x	-255.40%
2016-06-30	AU$4.58 Million ≈ $3.24 Million	AU$-2.03 Million ≈ $-1.43 Million	-0.442x	-347.26%
2015-06-30	AU$7.09 Million ≈ $5.02 Million	AU$1.27 Million ≈ $897.81K	0.179x	+112.01%
2014-06-30	AU$2.09 Million ≈ $1.48 Million	AU$-3.11 Million ≈ $-2.20 Million	-1.489x	-144.27%
2013-06-30	AU$4.65 Million ≈ $3.29 Million	AU$-2.83 Million ≈ $-2.00 Million	-0.610x	-33.48%
2012-06-30	AU$5.27 Million ≈ $3.73 Million	AU$-2.41 Million ≈ $-1.70 Million	-0.457x	+50.63%
2011-06-30	AU$2.02 Million ≈ $1.43 Million	AU$-1.87 Million ≈ $-1.32 Million	-0.925x	+6.96%
2010-06-30	AU$1.34 Million ≈ $951.04K	AU$-1.34 Million ≈ $-945.75K	-0.994x	-18.94%
2009-06-30	AU$3.93 Million ≈ $2.78 Million	AU$-3.28 Million ≈ $-2.32 Million	-0.836x	-55.71%
2008-06-30	AU$6.33 Million ≈ $4.48 Million	AU$-3.40 Million ≈ $-2.41 Million	-0.537x	-20.59%
2007-06-30	AU$6.02 Million ≈ $4.26 Million	AU$-2.68 Million ≈ $-1.90 Million	-0.445x	+1.08%
2006-06-30	AU$8.79 Million ≈ $6.22 Million	AU$-3.96 Million ≈ $-2.80 Million	-0.450x	+12.43%
2005-06-30	AU$10.86 Million ≈ $7.69 Million	AU$-5.59 Million ≈ $-3.95 Million	-0.514x	-298.62%
2004-06-30	AU$17.13 Million ≈ $12.12 Million	AU$-2.21 Million ≈ $-1.56 Million	-0.129x	+57.16%
2002-06-30	AU$13.48 Million ≈ $9.54 Million	AU$-4.06 Million ≈ $-2.87 Million	-0.301x	--

About Percheron Therapeutics Ltd

AU:PER Australia Drug Manufacturers - Specialty & Generic

Market Cap

$6.16 Million

AU$8.70 Million AUD

Market Cap Rank

#27955 Global

#1498 in Australia

Share Price

AU$0.01

Change (1 day)

+0.00%

52-Week Range

AU$0.01 - AU$0.01

All Time High

AU$0.34